ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
20 Dec 2019

Acarix AB: Redeye initiates coverage of Acarix

Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system's invention of coronary artery di...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
16 Dec 2019

Acarix submits FDA application

Press release Malmö, Sweden 16 December, 2019 Acarix submits FDA application Acarix AB (publ) (ACARIX: FN Stockholm) today anno...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
16 Dec 2019

Acarix lämnar in FDA-ansökan

Pressmeddelande Malmö, Sverige, 16 december, 2019 Acarix lämnar in FDA-ansökan Acarix AB (publ) (ACARIX: FN Stockholm...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
05 Aug 2019

CADScor®System – Significantly more effective than current practice

Press release Malmö August 5, 2019CADScor®System – Significantly more effective than current practice Acarix AB (publ) (...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
05 Aug 2019

CADScor®System – Betydligt effektivare än nuvarande metoder

Press release Malmö Augusti 5, 2019CADScor®System – Betydligt effektivare än nuvarande metoder Acarix AB (publ) (AC...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
27 Jun 2019

Acarix CADScor®System – nu inkluderad i NICEs riktlinjer för vård och hälsa

Press release Malmö Juni 27, 2019Acarix CADScor®System – nu inkluderad i NICEs riktlinjer för vård och hä...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
27 Jun 2019

Acarix CADScor®System included in NICE guidelines (UK)

Press release Malmö June 27, 2019Acarix CADScor®System included in NICE guidelines (UK) Acarix AB (publ) (ACARIX: FN Stockholm...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
07 Jun 2019

Acarix presenterar på Redeye Growth Day, 10 juni 2019

Acarix presenterar på Redeye Growth Day, 10 juni 2019Den 10 juni kl. 15.40 presenterar Per Persson, VD för Acarix, den senas...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
07 Jun 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019On Monday, June the 10th at 3.40 PM, Per Persson CEO for Acarix, will ...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
15 Feb 2019

Acarix anpassar processen för tysk ersättning – Lämnar in ny dokumentation i slutet av februari 2019

Press release Malmö, 15 februari, 2019Acarix anpassar processen för tysk ersättning- Lämnar in ny dokumentation i s...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
15 Feb 2019

Acarix adapts pathway for German reimbursement – Submission of new dossier by the end of February 2019

Press release Malmö, February 15, 2019Acarix adapts pathway for German reimbursement- Submission of new dossier by the end of Febr...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
17 Dec 2018

Acarix rapporterar om första patienten i ny klinisk studie för att spåra hjärtsvikt

Pressmeddelande Malmö, Sverige 17 december 2018Acarix rapporterar om första patienten i ny klinisk studie för att sp&ari...
Continue reading
  • «
  • ‹
  • 16
  • 17
  • 18
  • 19
  • 20
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.